Navigation Links
'Cancer Research' Has Published a Paper on the Activity of MM-121, an ErbB3 Inhibitor, in Ligand-dependent Tumors
Date:3/16/2010

/2 study of MM-121 combined with the EGFR inhibitor Tarceva® in patients with non small cell lung cancer.

About Merrimack
Merrimack is a biopharmaceutical company dedicated to the discovery and development of novel medicines for the treatment of cancer and inflammation. The Company is advancing a robust pipeline of engineered therapeutics paired with molecular diagnostics. Merrimack’s first two oncology candidates, MM-121, partnered with sanofi-aventis, and MM-111, are in Phase 1 clinical testing with multiple pre-clinical development and research stage programs in the pipeline. MM-121 and MM-111 are investigational drugs and have not been approved by the U.S. Food and Drug Administration or any international regulatory agency. The Company’s proprietary Network Biology discovery platform, developed with the help of leading scientists from MIT and Harvard, integrates the fields of engineering, biology, and computing to enable mechanism-based, model driven discovery and development of both therapeutics and diagnostics. Merrimack is a privately-held company based in Cambridge, Massachusetts. For additional information, please visit http://www.merrimackpharma.com.

Copies of the article can be found at http://cancerres.aacrjournals.org/.

###

Read the full story at http://www.prweb.com/releases/2010/03/prweb3733734.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2

Related biology technology :

1. Tianyin Pharmaceutical Co., Inc. Expects to Benefit from the Recently Published Guide to Pricing Reform for Medicine and Medical Services
2. ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology
3. ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ
4. Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today
5. Boston University Periodontal Study on Imagenetix Compound Published in The Journal of Periodontology
6. Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals Lead Antibody
7. Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration
8. Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax
9. New Report Just Published: World Prostate Cancer Therapeutics Market Report
10. New Report Just Published: World Endoscopy Systems Market Report
11. AEterna Zentaris: New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Cancer Research' Has Published a Paper on the Activity of MM-121, an ErbB3 Inhibitor, in Ligand-dependent Tumors
(Date:1/15/2014)... (PRWEB) January 15, 2014 Freeslate, ... solutions, today announced that Lupin Limited, one of India’s ... CM Protégé PharmD System for high throughput ... India, is focused on a wide range of quality, ...
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: 6 ... Almshouse Road, Warrington, Pa. , Details: The Hepatitis ... finding a cure for hepatitis B and improving the quality ... Crystal Ball on Friday, April 11 at Warrington Country Club ...
(Date:1/14/2014)... a leading provider of strategic communications services to corporations and organizations ... the United States and Europe ... is returning to the firm,s Washington, D.C. ... than two years of service as Associate Commissioner for the Office ...
(Date:1/14/2014)... , Jan. 14, 2014 The largest ... research medicinal plants and therapeutic derivatives thereof has ... professionals, and researchers about the challenges of adulterated ... http://photos.prnewswire.com/prnh/20100430/DC95601LOGO ) The Society for ...
Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8
... RESULTS Confirmation of Annual and Special General ... Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ANP), a ... conference call discussing its,financial results for the third quarter ... 11:00 AM ET (8:00 AM Pacific)., The Company,s ...
... Demonstrates Selective Survival Advantage of ZFN-Treated Immune ... WASHINGTON and RICHMOND, Calif., Oct. 28 ,Sangamo ... the presentation,of data demonstrating that human CD4 T-cells ... treatment with zinc finger DNA-binding,protein nucleases (ZFN(TM)) resulting ...
... Inc. (NYSE: BEC ), announced today that ... Health to provide a broad range of core,laboratory ... over,six years. Adventist Health is a not-for-profit, faith-based ... and Washington., (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ), ...
Cached Biology Technology:Notice of conference call and webcast 2Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 2Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 3Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 4Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 5Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care 2
(Date:4/23/2014)... University of Exeter researcher has shed light on how ... in Australia,s remote outback have become reviled as pests ... of the Environment and Sustainability Institute at the University ... camel in Australia, from their historic role helping to ... as unwelcome "invader." , The deserts of the Australian ...
(Date:4/23/2014)... Los Angeles, London (April 23, 2014). "I think one can ... energy pathwayas well as doing everything else that we canthen ... says Tom Wigley, one of the world,s foremost climate researchers, ... Scientists , published by SAGE. Refusing to take significant action ... will eventually be needed to address the problem, Wigley explains ...
(Date:4/22/2014)... the Florida campus of The Scripps Research Institute (TSRI) ... but previously unknown role in learning and memory formation. ... for a protein known as RGS7, was published April ... publisher supported by the Howard Hughes Medical Institute, the ... is a critical building block that regulates a fundamental ...
Breaking Biology News(10 mins):How Australia got the hump with 1 million feral camels 2How Australia got the hump with 1 million feral camels 3Is nuclear power the only way to avoid geoengineering? 2Scientists identify critical new protein complex involved in learning and memory 2
... may have some new motivations to serve their kids vegetables. ... Nutrition, found that by simply serving vegetables with dinner, the ... to be more thoughtful and attentive. , "Most parents ... only 23% of American dinners," said lead author Brian Wansink, ...
... new consensus statement issued by the Hinxton Group, ... and regulation. Specifically, tension between intellectual property ... also between eastern and western cultures, national and ... systems. The consensus, titled Statement on Data ...
... AMHERST, Mass. Military uniforms of the future may ... thanks to research by teams at the University of ... a nanotube-based fabric that repels chemical and biological agents. ... Watkins, collaborating with team leader Francesco Fornasiero of Lawrence ...
Cached Biology News:East Asia faces unique challenges, opportunities for stem cell innovation 2East Asia faces unique challenges, opportunities for stem cell innovation 3Developing 'second skin' military fabric to repel chemical and biological agents 2Developing 'second skin' military fabric to repel chemical and biological agents 3
...
... The Thermo Labsystems Wellmix is a high-quality ... time settings. The shaking speed is adjustable ... frequency, high speed and a small orbit ... The shaking time is quick and easy ...
Mouse monoclonal [AZ24] to Polo like kinase ( Abpromise for all tested applications)....
... together two mature, well-understood technologies: grating-based ... This combination produces a sensitive and ... of molecular binding events without the ... capture molecules are immobilized on the ...
Biology Products: